| 312- | AgNPs, | wortm, | Inhibition of autophagy enhances the anticancer activity of silver nanoparticles |
| - | vitro+vivo, | Cerv, | HeLa |
| 309- | AgNPs, | Interference of silver, gold, and iron oxide nanoparticles on epidermal growth factor signal transduction in epithelial cells |
| - | in-vitro, | NA, | A431 |
| 306- | AgNPs, | Cancer Therapy by Silver Nanoparticles: Fiction or Reality? |
| - | Analysis, | NA, | NA |
| 305- | AgNPs, | Activity and pharmacology of homemade silver nanoparticles in refractory metastatic head and neck squamous cell cancer |
| - | Case Report, | HNSCC, | NA |
| 345- | AgNPs, | Antitumor activity of silver nanoparticles in Dalton’s lymphoma ascites tumor model |
| - | vitro+vivo, | lymphoma, | NA |
| 344- | AgNPs, | Cytotoxicity and ROS production of manufactured silver nanoparticles of different sizes in hepatoma and leukemia cells |
| - | in-vitro, | Liver, | HepG2 |
| 374- | AgNPs, | Silver nanoparticles selectively treat triple‐negative breast cancer cells without affecting non‐malignant breast epithelial cells in vitro and in vivo |
| - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vivo, | NA, | NA |
| 373- | AgNPs, | Cytotoxic Potential and Molecular Pathway Analysis of Silver Nanoparticles in Human Colon Cancer Cells HCT116 |
| - | in-vitro, | Colon, | HCT116 |
| - | in-vitro, | Hepat, | HepG2 |
| 371- | AgNPs, | Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549 |
| - | in-vitro, | Lung, | A549 |
| 370- | AgNPs, | Differential genotoxicity mechanisms of silver nanoparticles and silver ions |
| - | in-vitro, | lymphoma, | TK6 |
| 369- | AgNPs, | Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis |
| - | in-vitro, | Liver, | NA |
| 368- | AgNPs, | In vitro evaluation of silver nanoparticles on human tumoral and normal cells |
| - | in-vitro, | Var, | NA |
| 367- | AgNPs, | Presence of an Immune System Increases Anti-Tumor Effect of Ag Nanoparticle Treated Mice |
| - | in-vivo, | NA, | NA |
| 366- | AgNPs, | Silver nanoparticles inhibit the function of hypoxia-inducible factor-1 and target genes: insight into the cytotoxicity and antiangiogenesis |
| - | in-vitro, | BC, | MCF7 |
| 365- | AgNPs, | Silver nanoparticles affect glucose metabolism in hepatoma cells through production of reactive oxygen species |
| - | in-vitro, | Hepat, | HepG2 |
| 364- | AgNPs, | Differential Action of Silver Nanoparticles on ABCB1 (MDR1) and ABCC1 (MRP1) Activity in Mammalian Cell Lines |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Hepat, | HepG2 | - | in-vitro, | CRC, | SW-620 |
| 363- | AgNPs, | Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis |
| 362- | AgNPs, | Comparative and Mechanistic Study on the Anticancer Activity of Quinacrine-Based Silver and Gold Hybrid Nanoparticles in Head and Neck Cancer |
| - | vitro+vivo, | SCC, | SCC9 |
| 361- | AgNPs, | Annona muricata assisted biogenic synthesis of silver nanoparticles regulates cell cycle arrest in NSCLC cell lines |
| - | in-vitro, | Lung, | A549 |
| 359- | AgNPs, | Anti-cancer & anti-metastasis properties of bioorganic-capped silver nanoparticles fabricated from Juniperus chinensis extract against lung cancer cells |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Nor, | HEK293 |
| 346- | AgNPs, | RSQ, | Investigating Silver Nanoparticles and Resiquimod as a Local Melanoma Treatment |
| - | in-vivo, | Melanoma, | SK-MEL-28 | - | in-vivo, | Melanoma, | WM35 |
| 347- | AgNPs, | The Role of Silver Nanoparticles in the Diagnosis and Treatment of Cancer: Are There Any Perspectives for the Future? |
| - | Review, | NA, | NA |
| - | in-vitro, | BC, | MCF7 |
| 349- | AgNPs, | Insight into the molecular mechanism, cytotoxic, and anticancer activities of phyto-reduced silver nanoparticles in MCF-7 breast cancer cell lines |
| - | in-vitro, | BC, | MCF7 |
| 350- | AgNPs, | Cytotoxic and Apoptotic Effects of Green Synthesized Silver Nanoparticles via Reactive Oxygen Species-Mediated Mitochondrial Pathway in Human Breast Cancer Cells |
| - | in-vitro, | BC, | MCF7 |
| 351- | AgNPs, | Study of antitumor activity in breast cell lines using silver nanoparticles produced by yeast |
| - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | T47D |
| 352- | AgNPs, | Synthesis of silver nanoparticles (Ag NPs) for anticancer activities (MCF 7 breast and A549 lung cell lines) of the crude extract of Syzygium aromaticum |
| - | in-vitro, | BC, | MCF7 |
| - | in-vitro, | neuroblastoma, | SH-SY5Y |
| 355- | AgNPs, | Cytotoxicity and Genotoxicity of Biogenic Silver Nanoparticles in A549 and BEAS-2B Cell Lines |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | NA, | BEAS-2B |
| - | in-vitro, | BC, | MCF7 | - | in-vitro, | Bladder, | HTB-22 |
| 357- | AgNPs, | Hypoxia-mediated autophagic flux inhibits silver nanoparticle-triggered apoptosis in human lung cancer cells |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Lung, | L132 |
| 358- | AgNPs, | Preparation of triangular silver nanoparticles and their biological effects in the treatment of ovarian cancer |
| - | vitro+vivo, | Ovarian, | SKOV3 |
| 360- | AgNPs, | Moringa, | Cytotoxic and Genotoxic Evaluation of Biosynthesized Silver Nanoparticles Using Moringa oleifera on MCF-7 and HUVEC Cell Lines |
| - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | HUVECs |
| 353- | AgNPs, | The mechanism of cell death induced by silver nanoparticles is distinct from silver cations |
| - | in-vitro, | BC, | SUM159 |
| 377- | AgNPs, | Anticancer Action of Silver Nanoparticles in SKBR3 Breast Cancer Cells through Promotion of Oxidative Stress and Apoptosis |
| - | in-vitro, | BC, | SkBr3 |
| 403- | AgNPs, | RF, | Synergetic effects of silver and gold nanoparticles in the presence of radiofrequency radiation on human kidney cells |
| - | in-vitro, | NA, | HNK |
| - | in-vitro, | BC, | MCF7 |
| 376- | AgNPs, | Antitumor activity of colloidal silver on MCF-7 human breast cancer cells |
| - | in-vitro, | BC, | MCF7 |
| 400- | AgNPs, | MF, | Polyvinyl Alcohol Capped Silver Nanostructures for Fortified Apoptotic Potential Against Human Laryngeal Carcinoma Cells Hep-2 Using Extremely-Low Frequency Electromagnetic Field |
| - | in-vitro, | Laryn, | HEp2 |
| 399- | AgNPs, | SIL, | Cytotoxic potentials of silibinin assisted silver nanoparticles on human colorectal HT-29 cancer cells |
| - | in-vitro, | CRC, | HT-29 |
| 398- | AgNPs, | Silver nanoparticles induced testicular damage targeting NQO1 and APE1 dysregulation, apoptosis via Bax/Bcl-2 pathway, fibrosis via TGF-β/α-SMA upregulation in rats |
| - | in-vivo, | Testi, | NA |
| 397- | AgNPs, | GEM, | Silver nanoparticles enhance the apoptotic potential of gemcitabine in human ovarian cancer cells: combination therapy for effective cancer treatment |
| - | in-vitro, | Ovarian, | A2780S |
| 396- | AgNPs, | Systemic Evaluation of Mechanism of Cytotoxicity in Human Colon Cancer HCT-116 Cells of Silver Nanoparticles Synthesized Using Marine Algae Ulva lactuca Extract |
| - | in-vitro, | Colon, | HCT116 |
| 395- | AgNPs, | The apoptotic and genomic studies on A549 cell line induced by silver nitrate |
| - | in-vitro, | Lung, | A549 |
| 394- | AgNPs, | Anticancer activity of Moringa oleifera mediated silver nanoparticles on human cervical carcinoma cells by apoptosis induction |
| - | in-vitro, | Cerv, | HeLa |
| 393- | AgNPs, | Green synthesized plant-based silver nanoparticles: therapeutic prospective for anticancer and antiviral activity |
| - | in-vitro, | NA, | HCT116 |
| 392- | AgNPs, | Biogenic silver nanoparticles synthesized from Piper longum fruit extract inhibit HIF-1α/VEGF mediated angiogenesis in prostate cancer cells |
| 391- | AgNPs, | Silver nanoparticles inhibit VEGF-and IL-1β-induced vascular permeability via Src dependent pathway in porcine retinal endothelial cells |
| - | in-vitro, | Nor, | NA |
| 389- | AgNPs, | Citrate, | Silver Citrate Nanoparticles Inhibit PMA-Induced TNFα Expression via Deactivation of NF-κB Activity in Human Cancer Cell-Lines, MCF-7 |
| - | in-vitro, | BC, | MCF7 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid